Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort:A population-based cohort study in the Netherlands using the PHARMO Database Network
This study estimated the incidence of malignancy in patients with multiple sclerosis (MS) versus a matched general population cohort in the Netherlands. Adults with a diagnosis of MS between 2006 and 2014 in the General Practitioner (GP) Database of the PHARMO Database Network with ≥ 1 year of patient history were matched to four non-MS individuals based on year of birth, sex, and GP practice. Patients were followed-up until the earliest malignancy diagnosis, death, or end of data collection. Age-adjusted incidence rates (IR) were measured overall and by cancer type. Standardized incidence rat... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | Kuiper , J G , Overbeek , J A , Foch , C , Boutmy , E & Sabidó , M 2022 , ' Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort : A population-based cohort study in the Netherlands using the PHARMO Database Network ' , Journal of Clinical Neuroscience , vol. 103 , pp. 49-55 . https://doi.org/10.1016/j.jocn.2022.06.025 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26845910 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://research.vumc.nl/en/publications/636257ed-f5ac-400a-8920-2f2ebb87cf96 |